KRAS mutant colorectal tumors: Past and present

af Brand, Toni M., Wheeler, Deric L.
Udgivet 2012

Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab

af Brand, Toni M, Iida, Mari, Wheeler, Deric L
Udgivet 2011

The Nuclear Epidermal Growth Factor Receptor Signaling Network and its Role in Cancer

af Brand, Toni M., Iida, Mari, Li, Chunrong, Wheeler, Deric L.
Udgivet 2011

Yes and Lyn play a role in nuclear translocation of the Epidermal Growth Factor Receptor

af Iida, Mari, Brand, Toni M., Campbell, David A, Li, Chunrong, Wheeler, Deric L.
Udgivet 2012

Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3

af Brand, Toni M., Iida, Mari, Luthar, Neha, Wleklinski, Matthew J., Starr, Megan M., Wheeler, Deric L.
Udgivet 2013

Nuclear EGFR as a Molecular Target in Cancer

af Brand, Toni M., Iida, Mari, Luthar, Neha, Starr, Megan M., Huppert, Evan J., Wheeler, Deric L.
Udgivet 2013

Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximab

af Iida, Mari, Brand, Toni M., Campbell, David A., Starr, Megan M., Luthar, Neha, Traynor, Anne M., Wheeler, Deric L.
Udgivet 2013

Human Epidermal Growth Factor Receptor 3 (HER3) Blockade with U3-1287/AMG888 Enhances the Efficacy of Radiation Therapy in Lung and Head and Neck Carcinoma

af Li, Chunrong, Brand, Toni M., Iida, Mari, Huang, Shyhmin, Armstrong, Eric A., van der Kogel, Albert, Wheeler, Deric L.
Udgivet 2013

Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab

af Brand, Toni M, Dunn, Emily F, Iida, Mari, Myers, Rebecca A, Kostopoulos, Kellie T, Li, Chunrong, Peet, Chimera R, Wheeler, Deric L
Udgivet 2011

Nuclear Epidermal Growth Factor Receptor is a Functional Molecular Target in Triple-Negative Breast Cancer

af Brand, Toni M., Iida, Mari, Luthar, Neha, Kostopoulos, Kellie T., Corrigan, Kelsey L., Wleklinski, Matthew J., Yang, David, Wisinski, Kari B., Salgia, Ravi, Wheeler, Deric L.
Udgivet 2014

BET inhibition overcomes receptor tyrosine kinase-mediated cetuximab resistance in HNSCC

af Leonard, Brandon, Brand, Toni M, O’Keefe, Rachel A, Lee, Eliot D, Zeng, Yan, Kemmer, Jacquelyn D, Li, Hua, Grandis, Jennifer R, Bhola, Neil E
Udgivet i Cancer Res (2018)

Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab

af Iida, Mari, Brand, Toni M, Starr, Megan M, Li, Chunrong, Huppert, Evan J, Luthar, Neha, Pedersen, Mikkel W, Horak, Ivan D, Kragh, Michael, Wheeler, Deric L
Udgivet 2013

Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

af Iida, Mari, Brand, Toni M, Starr, Megan M, Huppert, Evan J, Luthar, Neha, Bahrar, Harsh, Coan, John P, Pearson, Hannah E, Salgia, Ravi, Wheeler, Deric L
Udgivet i Mol Cancer (2014)

AXL mediates resistance to cetuximab therapy

af Brand, Toni M., Iida, Mari, Stein, Andrew P., Corrigan, Kelsey L., Braverman, Cara, Luthar, Neha, Toulany, Mahmoud, Gill, Parkash S., Salgia, Ravi, Kimple, Randall J., Wheeler, Deric L.
Udgivet 2014

The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor

af Brand, Toni M., Iida, Mari, Corrigan, Kelsey L., Braverman, Cara M., Coan, John P., Flanigan, Bailey G., Stein, Andrew P., Salgia, Ravi, Rolff, Jana, Kimple, Randall J., Wheeler, Deric L.
Udgivet i Sci Signal (2017)

NUCLEAR EGFR PROTEIN EXPRESSION PREDICTS POOR SURVIVAL IN EARLY STAGE NON-SMALL CELL LUNG CANCER

af Traynor, Anne M., Weigel, Tracey L., Oettel, Kurt R., Yang, David T., Zhang, Chong, Kim, KyungMann, Salgia, Ravi, Iida, Mari, Brand, Toni M., Hoang, Tien, Campbell, Toby C., Hernan, Hilary R., Wheeler, Deric L.
Udgivet 2013

Combination MET inhibition and Topoisomerase I inhibition block cell growth of Small Cell Lung Cancer

af Rolle, Cleo E., Kanteti, Rajani, Surati, Mosmi, Nandi, Suvobroto, Dhanasingh, Immanuel, Yala, Soheil, Tretiakova, Maria, Arif, Qudsia, Hembrough, Todd, Brand, Toni M., Wheeler, Deric L., Husain, Aliya N., Vokes, Everett E., Bharti, Ajit, Salgia, Ravi
Udgivet i Mol Cancer Ther (2013)

Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab

af Iida, Mari, Bahrar, Harsh, Brand, Toni M, Pearson, Hannah E, Coan, John P, Orbuch, Rachel A, Flanigan, Bailey G, Swick, Adam D, Prabakaran, Prashanth, Lantto, Johan, Horak, Ivan D., Kragh, Michael, Salgia, Ravi, Kimple, Randy J, Wheeler, Deric L
Udgivet i Mol Cancer Ther (2016)

Human papillomavirus regulates HER3 expression in head and neck cancer: implications for targeted HER3 therapy in HPV(+) patients

af Brand, Toni M., Hartmann, Stefan, Bhola, Neil E., Peyser, Noah D., Li, Hua, Zeng, Yan, Wechsler, Erin Isaacson, Ranall, Max V., Bandyopadhyay, Sourav, Duvvuri, Umamaheswar, LaVallee, Theresa M., Jordan, Richard C.K., Johnson, Daniel E., Grandis, Jennifer R.
Udgivet i Clin Cancer Res (2016)

Multiple Routes to Oncogenesis are Promoted by the Human Papillomavirus-Host Protein Network

af Eckhardt, Manon, Zhang, Wei, Gross, Andrew M., Von Dollen, John, Johnson, Jeffrey R., Franks-Skiba, Kathleen E., Swaney, Danielle L., Johnson, Tasha L., Jang, Gwendolyn M., Shah, Priya S., Brand, Toni M., Archambault, Jacques, Kreisberg, Jason F., Grandis, Jennifer R., Ideker, Trey, Krogan, Nevan J.
Udgivet i Cancer Discov (2018)